![]() Another user reverted back to the trimmed-down (but still in need of work) version, but the aforementioned author reverted it back to his again. I did an initial overhaul, and two other users helped tweak it some, but the individual responsible for the bulk of the content was not pleased about this, reverted to the old version, and began a discussion. I recently came across the temazepam article and found it to be bloated, poorly cited, and generally messy. Walkerma has the latest file and will post on his Sandbox when he gets a chance I'm sure.- ChemSpiderMan ( talk) 16:47, 18 January 2008 (UTC) Would like to recruit editors to the "temazepam" article I have some other deadlines then will return to the project. I am taking a short hiatus but have progressed quite well. I look forward to any direct feedback or questions about the process I am taking with the curation project. I'll be adding a few comments to your sandbox page I hope that's OK. Cheers, Walkerma ( talk) 05:45, 8 January 2008 (UTC) I, for one, am immensely grateful that someone has taken this on. I will update this page as he sends me more. Some of these invite a decision by this project. I have posted a rough list on wiki, see User:Walkerma/Sandbox, where you can leave comments. If anyone has time to help me work on these, email me and I will send you the PDF I am trying to put some basic info onto Wikipedia and I will also try to post the PDFs on my college's website tomorrow. I don't feel right making decisions about drugboxes when I'm not a member of this project, and I also have limited time right now, so I'd like to ask for help from people here. He is using ACD/Name to generate IUPAC names, which scored very highly in this recent study (I was amazed to see how often even ChemDraw is wrong!). He has sent me a couple of PDF files listing probable errors (mostly in the IUPAC names). Somebody buy ChemSpiderMan a beer! that's awesome! Aj1976 ( talk) 03:53, 20 September 2008 (UTC) Obviously this is great news for us all round, but we need to get fixing the errors. Last I heard he'd spent over 36 hours of hard slog on this! His plan is then to link to Wikipedia from each relevant substance entry on his ChemSpider website. He is MANUALLY checking every IUPAC name and structure, as well as generating an InChI and InChiKey for each one. User:ChemSpiderMan (aka Antony Williams) has very kindly taken on an absolutely mammoth task - he is checking every single drugbox (and chembox)for accuracy. 93 Clean up requested pharmacology list - removing non notable requests.79 Dermatology in need of pharmacologic expertise.70 Wikipedia 0.7 articles have been selected for Pharmacology.68 Wikipedia:Articles for deletion/Apricitabine.66 Discussions about ChemSpider and Linkouts.62 Does this article belong within the project?.61 Potential new Alzheimer's Disease drug.57 Two new medically-related websites launching this year.53 Psychoactive drug - chart controversy.51 Changes to the WP:1.0 assessment scheme.48 Fact checking as regards supposed alkaloid 7-acetoxymitragynine.44 Category:pharmacology stubs subtypes.34 Hemostatic agent article and Antihemorrhagics.32 AfD nomination of Janet Wolfe and Wolfe Laboratories.29 Wikipedia:Articles for deletion/Paramax.27 CAS validation of CAS numbers: An update.13 Bioavailabiity vs oral bioavailability.11 Cleanup of copy&paste of product literature into articles.9 Request for an expert view on Resveratrol.5 Pharmacology Collaboration of the Month.4 IRC discussion on using Wikipedia chemistry pages to provide chemical data.2 Would like to recruit editors to the "temazepam" article.LifeBio Memory is also showing promise to improve person-centered care, health outcomes and social connections for the growing dementia population. Results were presented at the Alzheimer’s Association International Dementia (AAIC) Conference and found LifeBio Memory to be effective, efficient and preferred versus past life story methods. This is a $448,462 SBIR grant under award number R43AG076341-01. The company’s first SBIR award helped to develop LifeBio Memory, a voice-driven life story platform powered by AI and machine learning. The Benjamin Rose Institute on Aging, with funding from the National Institute on Aging, conducted focus groups to evaluate LifeBio Memory. This grant will involve developing LifeBio-ALZ, an artificial intelligence driven digital biomarker engine, leveraging natural conversation to widely scale accessibility for early detection and assessment of Alzheimer’s Disease progression. is proud to announce that a notice of award has been received for the company’s second SBIR grant, starting.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |